Kristine Golden
Physician Assistant · Carmichael, CANPI 1134318850
Payments from drug & device makers
Across 252 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$641
- GSK$472
- Novo Nordisk$348
- Takeda Pharmaceuticals U.S.A., Inc.$307
- Pfizer$267
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,605100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $1,025 |
| Lilly USA, LLC | 37 | $641 |
| GSK | 24 | $472 |
| Novo Nordisk | 19 | $348 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $307 |
| Pfizer | 13 | $267 |
| Exact Sciences | 10 | $221 |
| AstraZeneca | 11 | $203 |
| Boehringer Ingelheim | 9 | $177 |
| Sanofi-aventis U.S. LLC | 8 | $142 |
| Phathom Pharmaceuticals, Inc. | 7 | $104 |
| Bayer | 4 | $95 |
| Amgen | 5 | $78 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Amarin Pharma, Inc. | 3 | $59 |
| Merck | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Eisai Inc. | 2 | $30 |
| Vertex | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 2 | $27 |
| Ardelyx, Inc. | 1 | $27 |
| Novartis | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Abbott | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Sanofi | 1 | $14 |
| Tolmar, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$4,617 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 55 | $98,808 |
| OzempicSemaglutide | 39 | $63,607 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $48,577 |
| EliquisApixaban | 33 | $38,181 |
| LinzessLinaclotide | 12 | $17,233 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $15,602 |
| JardianceEmpagliflozin | 16 | $15,483 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 269 | $10,268 |
| Arnuity ElliptaFluticasone Furoate | 18 | $6,283 |
| QuviviqDaridorexant Hcl | 12 | $5,699 |
| Gabapentin | 75 | $5,374 |
| Celecoxib | 11 | $4,887 |
| Pregabalin | 68 | $3,633 |
| Tolterodine Tartrate ErTolterodine Tartrate | 16 | $2,480 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $2,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $641 | $98,80855 claims |
| Novo NordiskOzempic | $348 | $63,60739 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $472 | $54,86163 claims |
| PfizerEliquis | $267 | $38,18133 claims |
| AbbVieLinzess, Synthroid | $1,025 | $18,09726 claims |
| Boehringer IngelheimJardiance | $177 | $15,48316 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $12 | $5,69912 claims |
| Almatica Pharma LLCSertraline Hcl | $24 | $99795 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Carmichael
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.